Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (219)	4/17/1998 1:56:00 PM
From: incomep	Read Replies (3) of 1016

Hi guys: Would you guys allow me to post here. It is much pleasant. Sorry BigKNY3 if I ever offended you, I would still believe Edderd that MUSE is a good product. What I am concerned now is the abuse of Viagra if the person called Jim on the Pfe board is telling the truth. Since I am majoring in molecular biology, I would say that so far too little is known about PDE 5 inhibitors, especially at high dosage (100 mg). So far, the headache is surely a true thing for some ED patients. According the two mild ED patients I communicated with, this headache started on the back of the head, and last a couple hour to 7 hours. Aspirin can help. Also one has an unhappy feeling after sex when he took the 50 mg dosage. Dale, do you have any idea why the headache started at the back of the head? My reasonable guess is that inhibition of PDE3 in the eye signal cascade might send a sigal to the brain. But I really do not know. This whole section is so new for all of us. I think the price rise today comes from two rumors posted on the yahoo board few minute ago. Rumour from Yahoo board: have heard of 2 rumors on the street. I am not posting this to hype vivus stock. For the record I am long vivus so the shorts will indeed think that what I post is untrue. 1)CNBC will be airing a piece on vivus in the near future. I spoke with ir at vivus and they confirmed that they are speaking with CNBC about getting air time on an ED piece. I suspect that there will be input from all the ED players. I also suspect that Wilson will be interviewed. It probably will be similar to the report done last summer which involved Wilson and several doctors speaking about ED and available treatments. I don't recall for sure but I think there was a CEO from another ED company in that interview. 2)This one is a doozy. I was told that last year vivus was in talks in regards to being bought out. At the time the share price was around 50 presplit. I was also told that talks broke down because vivus management thought that a buy out in the 50's (25 now) was too low. I now hear (again rumor only), that management is at the table again discussing a merger or buyout agreement. I have heard of prices as low as 15 and as high as 25. If these rumors are true, there is some serious money to be made on the long side at these levels. I also spoke with vivus ir and was not given a clear answer ie I wasn't told that a takeover was going to occur but I also was not told that it was not going to occur. The latest news I heard on this rumor was today at about 11am EST. I think that all the accumulating of this stock from 12 on down was done by institutions with some type of knowledge in regards to this possible scenario. Again, I have no solid proof. Others should check with any and all other sources available to them. Good Luck. Buying at these levels IMO poses little if any down side risk and a lot of upside potential in the possibly short and most certainly long term outlook. ÿ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next